IP Library Granted Patent US 7,851,618
Granted Patent B2
US 7,851,618 · App. 10/565,799 · Granted Dec 14, 2010

Aminated complex-type sugar chain derivatives and process for the production thereof

Assignee: Otsuka Chemical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,851,618
App. No.
10/565,799
Granted
Dec 14, 2010
Kind
B2
Abstract

An aminated complex-type oligosaccharide derivative of the formula (1) wherein R 1 is H—(CO)—CH 2 X, —NH—(CO)—(CH 2 ) b —CH 2 X, isothiocyanate group, —NH—(CO) a —(CH 2 ) b —CO 2 H or —NH—(CO) a —(CH 2 ) b —CHO, X being a halogen atom, a being 0 or 1, b being an integer of 1 to 4, R 2 and R 3 are a hydrogen atom or a group of the formulae (2) to (5) and may be the same or different, except for the case where both R 2 and R 3 are hydrogen or the formula (5), and the case where one of R 2 and R 3 is a hydrogen atom, with the formula (5) serving as the other thereof.

Claims (9)

1. A glycopeptide comprising an aminated complex-type oligosaccharide of the formula (1)

wherein R 1 is —NH—(CO)—CH 2 X, X being a halogen atom, R 2 and R 3 are a hydrogen atom or a group of the formulae (2) to (5) and may be the same or different, except that R 2 and R 3 are not both hydrogen or the formula (5) at the same time and when one of R2 and R3 is hydrogen, the other is not the formula (5),

and the aminated complex-type oligosaccharide is bound to a thiol group of a peptide by displacement of halogen X of NH—(CO)—CH 2 X further wherein the glycopeptide has about 12 times higher resistance to Peptide-N Glycosidase F (PNGase F) than the glycopeptide comprising said aminated complex-type oligosaccharide of formula (1), wherein R1 is an asparagine.

2. A glycopeptide as defined in claim 1 wherein the glycopeptide is an antibody.

3. A process for preparing a uniform glycopeptide composition comprising steps of (a) and (b) that are performed at the same time,

(a) cleaving an asparagine-linked oligosaccharide of a glycopeptide from a peptide by Peptide-N Glycosidase F (PNGase F), wherein the resulting peptide has a thiol group, and

(b) bonding an aminated complex-type oligosaccharide of the formula (1)

wherein R 1 is —NH—(CO)—CH 2 X, X being a halogen atom, R 2 and R 3 are a hydrogen atom or a group of the formulae (2) to (5) and may be the same or different, except that R 2 and R 3 are not both hydrogen or the formula (5) at the same time and when on of R2 and R3 is hydrogen, the other is not the formula (5),

to the thiol group of the resulting peptide by displacement of halogen X of —NH—(CO)—CH 2 X.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2013
From: OTSUKA CHEMICAL CO., LTD.
To: GLYTECH, INC.
Reel/Frame 030723/0810 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2010
From: OTSUKA CHEMICAL CO., LTD.
To: OTSUKA CHEMICAL HOLDINGS CO., LTD.
Reel/Frame 024033/0568 →
CHANGE OF NAME Recorded Mar 5, 2010
From: OTSUKA CHEMICAL HOLDINGS CO., LTD.
To: OTSUKA CHEMICAL CO., LTD.
Reel/Frame 024033/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2006
From: FUKAE, KAZUHIRO
To: OTSUKA CHEMICAL CO., LTD.
Reel/Frame 017505/0972 →
Priority Claims (1)
JP 2003-202594 · Jul 28, 2003 · national
Continuity (1)
Related Publication 20070060543A1 · Mar 15, 2007